ArticleNature communications2018

Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFβ enhance the efficacy of cancer immunotherapy.

Rajani Ravi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.